Impaired endothelial function in preadolescent children with type 1 diabetes
Related Experiment Video
Updated: Jun 4, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Ghufran S Babar1, Hanaa Zidan, Michael E Widlansky
1Department of Pediatric Endocrinology, Children’s Mercy Hospital, Kansas City, Missouri, USA.
Insights
Preadolescent children with type 1 diabetes show early signs of vascular inflammation and impaired blood vessel function, indicating increased future cardiovascular risk. These findings highlight the importance of monitoring vascular health in young diabetics.
Area of Science:
- Pediatric Endocrinology
- Cardiovascular Research
- Vascular Biology
Background:
- Type 1 diabetes (T1D) in children can lead to long-term complications, including cardiovascular disease.
- Early detection of vascular dysfunction and inflammation is crucial for risk stratification in pediatric T1D.
- Endothelial dysfunction and systemic inflammation are recognized predictors of future cardiovascular events.
Purpose of the Study:
- To assess endothelial dysfunction using flow-mediated dilation (FMD) and carotid intima-media thickness (c-IMT).
- To investigate vascular inflammatory biomarkers in preadolescent children with T1D.
- To establish the relationship between T1D, inflammation, and early vascular changes.
Main Methods:
- A study involving 21 preadolescent children with T1D and 15 healthy siblings.
- Measurements included fasting plasma glucose (FPG), HbA1c, lipid profile, hs-CRP, fibrinogen, homocysteine, and RBC folate.
- Vascular assessment via high-resolution ultrasound for c-IMT and brachial artery FMD%.
Main Results:
- Children with T1D exhibited higher FPG, HbA1c, and hs-CRP levels compared to controls.
- No significant differences were observed in BMI, homocysteine, fibrinogen, RBC folate, or c-IMT between groups.
- Preadolescent T1D patients demonstrated significantly lower FMD% (indicating endothelial dysfunction) than healthy siblings.
Conclusions:
- Preadolescent children with T1D show evidence of low-grade vascular inflammation and reduced FMD.
- Endothelial dysfunction and systemic inflammation are present early in T1D, even before structural changes like increased c-IMT.
- These findings suggest that early cardiovascular risk is established in childhood T1D, necessitating proactive management.
Objective:
We evaluated the prevalence of endothelial dysfunction as measured by flow-mediated dilatation (FMD) of the brachial artery and carotid intima-media thickness (c-IMT) in relationship to vascular inflammatory biomarkers in preadolescent children with type 1 diabetes.
Research Design And Methods:
We studied 21 type 1 diabetic children (aged 8.3 ± 0.3 years with diabetes duration of 4.3 ± 0.4 years) and 15 group-matched healthy siblings (aged 7.6 ± 0.3 years). Fasting plasma glucose (FPG), lipid profile, HbA(1c), high-sensitivity C-reactive protein (hs-CRP), fibrinogen, homocysteine, and erythrocyte (red blood cell [RBC]) folate were evaluated in all subjects. Each subject underwent c-IMT and brachial artery FMD percentage (FMD%) measurements using high-resolution vascular ultrasound.
Results:
Type 1 diabetic children had higher FPG (173.4 ± 7.9 mg/dL vs. 81.40 ± 1.7 mg/dL; P < 0.0001), HbA(1c) (8.0 ± 0.2% vs. 5.0 ± 0.1%; P < 0.0001), and hs-CRP (1.8 ± 0.3 vs. 0.70 ± 0.2; P = 0.017) than control children without significant differences in BMI, homocysteine, and fibrinogen levels; RBC folate content; and c-IMT between the groups. Children with type 1 diabetes had lower FMD% than control children (7.1 ± 0.8% vs. 9.8 ± 1.1%; P = 0.04), whereas c-IMT did not differ between groups.
Conclusions:
Preadolescent children with type 1 diabetes and mean diabetes duration of 4 years displayed evidence of low-intensity vascular inflammation and attenuated FMD measurements. These data suggest that endothelial dysfunction and systemic inflammation, known harbingers of future cardiovascular risk, are present even in preadolescent children.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetic Retinopathy
Type I Diabetes II: Pathophysiology
Type I Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
